ATRS
Antares Pharma, Inc.
ATRS
ATRS
Delisted
ATRS was delisted on the 23rd of May, 2022.
171 hedge funds and large institutions have $339M invested in Antares Pharma, Inc. in 2021 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 55 increasing their positions, 47 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
less first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 174 → 171 (-3)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
171
Holding in Top 10
3
Calls
$1.18M
Puts
$1.07M
Top Buyers
| 1 | +$21.2M | |
| 2 | +$4.83M | |
| 3 | +$4.64M | |
| 4 |
Morgan Stanley
New York
|
+$4.1M |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$3.79M |
Top Sellers
| 1 | -$6.86M | |
| 2 | -$3.48M | |
| 3 | -$2.13M | |
| 4 |
Fuller & Thaler Asset Management
San Mateo,
California
|
-$2.04M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.03M |